| scholarly article | Q13442814 |
| P2093 | author name string | Brian L Frey | |
| Lloyd M Smith | |||
| Alan D Attie | |||
| Michael R Shortreed | |||
| Mary E Rabaglia | |||
| Mark P Gray-Keller | |||
| P2860 | cites work | Overexpression and characterization of the human mitochondrial and cytosolic branched-chain aminotransferases | Q28262954 |
| Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene | Q28269681 | ||
| Diazoxide restores beta3-adrenergic receptor function in diet-induced obesity and diabetes | Q33181164 | ||
| Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. | Q37270892 | ||
| Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). | Q37371843 | ||
| Overexpression of constitutively activated glutamate dehydrogenase induces insulin secretion through enhanced glutamate oxidation | Q40628216 | ||
| Distinguishing Features of Leucine and α-Ketoisocaproate Sensing in Pancreatic β-Cells | Q40655102 | ||
| A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. | Q40734688 | ||
| L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase | Q41614642 | ||
| Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism | Q42475368 | ||
| Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study | Q42489566 | ||
| Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes | Q42523946 | ||
| The elevation of glutamate content and the amplification of insulin secretion in glucose-stimulated pancreatic islets are not causally related | Q44043453 | ||
| Differences between mouse and rat pancreatic islets: succinate responsiveness, malic enzyme, and anaplerosis | Q44058319 | ||
| Regulation of leucine-stimulated insulin secretion and glutamine metabolism in isolated rat islets | Q44223858 | ||
| A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. | Q44297979 | ||
| Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children | Q44496940 | ||
| Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K(ATP) channel opener. | Q44816765 | ||
| Interaction between BTBR and C57BL/6J genomes produces an insulin resistance syndrome in (BTBR x C57BL/6J) F1 mice. | Q50917448 | ||
| Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci. | Q51552683 | ||
| The influence of genetic background on the expression of the obese (ob) gene in the mouse | Q53909983 | ||
| Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. | Q53920238 | ||
| Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. | Q54081357 | ||
| P433 | issue | 2 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | E218-24 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
| P1476 | title | Alpha-Ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice | |
| P478 | volume | 289 |
| Q36586611 | A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility |
| Q42101100 | A method for mouse pancreatic islet isolation and intracellular cAMP determination |
| Q36451468 | A single-islet microplate assay to measure mouse and human islet insulin secretion |
| Q36297519 | Cholecystokinin expression in the β-cell leads to increased β-cell area in aged mice and protects from streptozotocin-induced diabetes and apoptosis |
| Q34132510 | Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival |
| Q42503904 | Enhanced mitochondrial metabolism may account for the adaptation to insulin resistance in islets from C57BL/6J mice fed a high-fat diet |
| Q34132215 | FoxM1 is up-regulated by obesity and stimulates beta-cell proliferation |
| Q46932225 | Fuel-induced amplification of insulin secretion in mouse pancreatic islets exposed to a high sulfonylurea concentration: role of the NADPH/NADP+ ratio |
| Q33657409 | Genetic validation of whole-transcriptome sequencing for mapping expression affected by cis-regulatory variation |
| Q36272452 | Global Identification of Protein Post-translational Modifications in a Single-Pass Database Search |
| Q35794958 | Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis |
| Q36309626 | Hippocampal Transcriptomic and Proteomic Alterations in the BTBR Mouse Model of Autism Spectrum Disorder |
| Q41314328 | Hypothalamic regulation of glucose-stimulated insulin secretion |
| Q34510196 | Integrative analysis of a cross-loci regulation network identifies App as a gene regulating insulin secretion from pancreatic islets |
| Q87929725 | Islet proteomics reveals genetic variation in dopamine production resulting in altered insulin secretion |
| Q34263728 | Leucine metabolism in regulation of insulin secretion from pancreatic beta cells |
| Q35216708 | Loss of PDGF-B activity increases hepatic vascular permeability and enhances insulin sensitivity |
| Q34737010 | Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes |
| Q37016691 | Metabolic cycling in control of glucose-stimulated insulin secretion |
| Q37400761 | Metabolomics applied to diabetes research: moving from information to knowledge |
| Q37403962 | Nutrient modulation of insulin secretion |
| Q50088043 | Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes |
| Q37060691 | Overexpression of pre-pro-cholecystokinin stimulates beta-cell proliferation in mouse and human islets with retention of islet function |
| Q39086901 | Oxo-4-methylpentanoic acid directs the metabolism of GABA into the Krebs cycle in rat pancreatic islets |
| Q41553184 | PWD/PhJ mice have a genetically determined increase in nutrient-stimulated insulin secretion |
| Q48088931 | Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus |
| Q28506444 | Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion |
| Q36867528 | Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion |
| Q38784608 | Role of prolyl hydroxylase domain proteins in the regulation of insulin secretion |
| Q34311608 | SORCS1 is necessary for normal insulin secretory granule biogenesis in metabolically stressed β cells |
| Q48096496 | Targeted Mass Spectrometry Approach Enabled Discovery of O-Glycosylated Insulin and Related Signaling Peptides in Mouse and Human Pancreatic Islets. |
| Q38943061 | The Pancreatic β-Cell: A Bioenergetic Perspective |
| Q36217634 | The Transcription Factor Nfatc2 Regulates β-Cell Proliferation and Genes Associated with Type 2 Diabetes in Mouse and Human Islets |
| Q39643761 | The dicarboxylate carrier plays a role in mitochondrial malate transport and in the regulation of glucose-stimulated insulin secretion from rat pancreatic beta cells |
| Q36066441 | The gastrin-releasing peptide analog bombesin preserves exocrine and endocrine pancreas morphology and function during parenteral nutrition |
| Q38830220 | The glutamine-alpha-ketoglutarate (AKG) metabolism and its nutritional implications |
| Q33883478 | The mitochondrial 2-oxoglutarate carrier is part of a metabolic pathway that mediates glucose- and glutamine-stimulated insulin secretion |
| Q34488824 | The role of leucine and its metabolites in protein and energy metabolism |
| Q28291461 | Transamination Is Required for α-Ketoisocaproate but Not Leucine to Stimulate Insulin Secretion* |
Search more.